This inventor holds 1 USPTO granted patent. Top assignee: House Ear Institute. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Xiankui Li
Introduction
Xiankui Li is a notable inventor based in Alhambra, California. He has made significant contributions to the field of biomedical research, particularly in the study of Schwannoma cell lines. His work has implications for understanding and treating conditions related to Neurofibromatosis type 2 (NF2).
Latest Patents
Xiankui Li holds a patent for a unique human Schwannoma cell line. This cell line is derived from a Schwann tumor in a patient with NF2 and is immortalized with HPV E6-E7 genes. The cell line features a unique splice site mutation of the NF2 gene. It is non-tumorigenic but exhibits altered growth properties, such as a higher proliferation rate and independence from Schwann cell growth factors. The patent also discloses methods for using this cell line in pharmacologic screening. He has 1 patent to his name.
Career Highlights
Xiankui Li is associated with the House Ear Institute, where he conducts research that contributes to advancements in medical science. His work focuses on the cellular mechanisms underlying Schwannoma and related conditions.
Collaborations
He collaborates with Gene Hung, who is also involved in research at the House Ear Institute. Their combined efforts aim to enhance the understanding of Schwannoma and its treatment.
Conclusion
Xiankui Li's innovative work in developing a Schwannoma cell line represents a significant advancement in biomedical research. His contributions have the potential to impact future pharmacological studies and treatments for NF2.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile